Danny Yeung Sheng-wu, CEO and co-founder of Prenetics, displays a biochip in the company’s laboratory for genetic testing in Quarry Bay, Hong Kong. Photo: Nora Tam

Prenetics is first Hong Kong firm to take genetic test kit for cancer risk direct to consumers

  • The kit will assess the user’s risk of developing eight hereditary cancers within his or her lifetime
  • The nascent consumer genetic-testing market is projected to grow at 15 per cent annually to reach US$928 million by 2023
Topic |   Health and wellness

TOP PICKS

Danny Yeung Sheng-wu, CEO and co-founder of Prenetics, displays a biochip in the company’s laboratory for genetic testing in Quarry Bay, Hong Kong. Photo: Nora Tam
READ FULL ARTICLE